Financials
- Market Capitalization 717.62 M
- Employee 196
- Founded 2013
- CEO N/A
- Website www.4dmoleculartherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QG40R88
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.1
Fiyat/satışlar oranı
5.1
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2612 | AVTX Avalo Therapeutics, Inc. - Common Stock | 13.23 USD | -3.08% | -9.38% | -19.48% | -4.06% | 709.52 M USD | ||
| 2615 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.64 USD | -2.38% | -5.75% | -17.17% | +8.61% | 729.73 M USD | ||
| 2628 | DSGN Design Therapeutics, Inc. - Common Stock | 10.92 USD | -6.27% | -12.08% | -25.76% | +61.78% | 683.39 M USD | ||
| 2636 | MDXG MiMedx Group, Inc - Common Stock | 4.82 USD | +3.21% | +5.93% | +6.17% | -26.75% | 702.57 M USD |